Cytokinetics | CYTK - Selling And Administration Expenses


Cytokinetics reported $158.75M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 124.9M 1.24M Sep/2025
Amgen USD 1.7B 9M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 1.79B 76M Sep/2025
Cytokinetics USD 158.75M 93.03M Sep/2025
Eisai JPY 103.86B 3.7B Sep/2025
Eli Lilly USD 2.74B 12.3M Sep/2025
Exelixis USD 103.13M 9.8M Sep/2025
Geron USD 39M 437K Sep/2025
Halozyme Therapeutics USD 37.53M 4.53M Sep/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Ligand Pharmaceuticals USD 28.45M 8.27M Sep/2025
Merck USD 2.63B 0 Sep/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025